Aaptamine attenuates the proliferation and progression of non-small cell lung carcinoma.
CONCLUSIONS: Aaptamine retarded the proliferation and invasion of NSCLC cells by selectively targeting the pathway PI3K/AKT/GSK3β suggesting it as a potential chemotherapeutic agent for repressing tumorigenesis and progression of NSCLC in humans.
PMID: 33027592 [PubMed - in process]
Source: Pharmaceutical Biology - Category: Drugs & Pharmacology Tags: Pharm Biol Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Lung Cancer | Molecular Biology | Non-Small Cell Lung Cancer